Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...

The authors emphasize the value of subgroup analyses for tracking patterns in spinal muscular atrophy (SMA), as opposed to ...

Antifibrotic treatment rates for IPF differ significantly between referral hospitals and general hospitals or clinics, with ...

Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

A review of recent clinical trial results for emerging HER2-directed therapies, including SOHO-01, inetetamab/pyrotinib, and ...

Real-world outcomes for HER2-positive NSCLC differ from clinical trials due to diverse patient populations and treatment ...

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...

On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The ...

Vermont achieved the highest ranking in maternal and infant health with a preterm birth rate of 7.7%, the lowest in the ...

The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections ...

An exploration of emerging strategies to overcome resistance to HER2-directed therapies based on ongoing research advancements.